Pancreatic Cancer Research

ResearcherAir Force Medical UniversityActive in the last 2 years

Jian‐Li Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7952-5667; OpenAlex author ID A5018051539. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer. Last author DOI 10.1038/s41420-025-02421-z↗
  2. CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2020.05.005↗
  3. Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. Co-author PMID 31312365↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xue Liang · 1 shared paper, 2025 · strength 0.25
  2. Zhi‐Nan Chen · 2 shared papers, 2019–2020 · strength 0.21
  3. Yinghui Zhou · 1 shared paper, 2020 · strength 0.12
  4. Liang Xu · 1 shared paper, 2019 · strength 0.09
  5. Bin Wang · 1 shared paper, 2019 · strength 0.09
  6. Xiaoqing Wu · 1 shared paper, 2019 · strength 0.09
  7. Xinyu Fan · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.